Clinical
RSSArticles
-
Use Best Practices to Screen Patients for Substance Use Disorder
OB/GYNs and family planning clinicians should screen all patients for substance use disorders, as recommended by researchers and professional guidelines. Recent guidelines from the American College of Obstetricians and Gynecologists’ Committee on Obstetric Practice recommend anyone who enters a physician’s office for reproductive health services receive a screening for a substance use disorder.
-
Pap Smear Management: An Update on Recent Recommendations
Despite its current prevalence in the care of patients, the Pap smear has been used for less than 100 years. A major advancement in the field of screening came in the late 1970s and early 1980s with the identification that the human papilloma virus (HPV). Since the year 2000, there have been multiple progressive cycles of updates to both screening and management guidelines as the result of our rapidly evolving understanding of HPV.
-
A New Nonhormonal Vaginal Gel Contraceptive
In this single-arm, open-label, Phase III study of a novel vaginal pH regulator gel among 1,384 sexually active women aged 18 to 35 years, the seven-cycle cumulative pregnancy rate was 13.7% (95% confidence interval, 10.0% to 17.5%).
-
Is Universal Rescreening of Pregnant Women for Hepatitis C Cost-Effective?
In this cost-effectiveness analysis study, the authors assessed the cost effectiveness of offering hepatitis C virus (HCV) antenatal rescreening to U.S. women who previously were screened HCV negative in a prior pregnancy.
-
Body Mass Index and Safety of Postpartum Tubal Ligation
In a single-institution, retrospective review of 3,670 postpartum tubal ligations performed after vaginal delivery, there was no association between increasing body mass index and surgical morbidity.
-
Biden-Harris Healthcare Team
Takes ShapeFauci moves front and center, Obama-era surgeon general returns.
-
Is There Bundle Branch Block?
Try to interpret the ECG in the figure without the benefit of any clinical information. What do you see?
-
Bamlanivimab Injection
Bamlanivimab is a neutralizing recombinant IgG1 monoclonal antibody that connects to the receptor-binding domain of the spike protein of SARS-CoV-2. The drug blocks attachment and entry of the virus into human cells.
-
When Aortic Stenosis Is Almost Severe: What Happens Next?
A study of patients with normal flow, low gradients, normal left ventricular systolic function but with calculated aortic valve areas <1.0 cm2 showed that about half of them progressed to severe aortic stenosis during the 25-month median follow-up period.
-
Rifampin vs. Isoniazid for Latent Tuberculosis
A health system cost comparison showed that four months of rifampin was safer and less expensive than nine months of isoniazid in high-income countries, medium-income countries, and African countries.